DXCM vs TSE · P/E 63, rev $2.50B vs rev $3.51B
DexCom Inc (DXCM) versus Trinseo SA (TSE) — a side-by-side from cached financials, not a winner call.
DexCom Inc (DXCM) is a medical devices company listed on US.
Trinseo SA (TSE) is a specialty chemicals company listed on NYSE.
Latest reported DXCM revenue for 2026-06-30 was $2.50B. Net income was $448.6M. DXCM currently screens at market cap $32.84B and trailing P/E 62.5.
Latest reported TSE revenue for 2024-12-31 was $3.51B. Net income was -$348.5M. Revenue was down 4.4% from 2023-12-31 to 2024-12-31. TSE currently screens at market cap $8.3M.
DXCM currently screens at market cap $32.84B and trailing P/E 62.5. TSE currently screens at market cap $8.3M.
Not investment advice. Open the DXCM and TSE stock pages for the full models.
Not investment advice.